HUP9800198A2 - 1-{4-[4-Aril-(vagy -heteroaril)-1-piperazinil]-butil}-1H-azol-származékok alkalmazása gyógyszerkészítmények előállítására - Google Patents

1-{4-[4-Aril-(vagy -heteroaril)-1-piperazinil]-butil}-1H-azol-származékok alkalmazása gyógyszerkészítmények előállítására

Info

Publication number
HUP9800198A2
HUP9800198A2 HU9800198A HUP9800198A HUP9800198A2 HU P9800198 A2 HUP9800198 A2 HU P9800198A2 HU 9800198 A HU9800198 A HU 9800198A HU P9800198 A HUP9800198 A HU P9800198A HU P9800198 A2 HUP9800198 A2 HU P9800198A2
Authority
HU
Hungary
Prior art keywords
piperazinyl
heteroaryl
aryl
butyl
azole derivatives
Prior art date
Application number
HU9800198A
Other languages
English (en)
Hungarian (hu)
Inventor
Jordi Frigola-Constansa
Original Assignee
Laboratorios Del Dr. Esteve S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Del Dr. Esteve S.A. filed Critical Laboratorios Del Dr. Esteve S.A.
Publication of HUP9800198A2 publication Critical patent/HUP9800198A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU9800198A 1995-12-12 1996-12-11 1-{4-[4-Aril-(vagy -heteroaril)-1-piperazinil]-butil}-1H-azol-származékok alkalmazása gyógyszerkészítmények előállítására HUP9800198A2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9514690A FR2742052B1 (fr) 1995-12-12 1995-12-12 Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports

Publications (1)

Publication Number Publication Date
HUP9800198A2 true HUP9800198A2 (hu) 1999-09-28

Family

ID=9485400

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9800198A HUP9800198A2 (hu) 1995-12-12 1996-12-11 1-{4-[4-Aril-(vagy -heteroaril)-1-piperazinil]-butil}-1H-azol-származékok alkalmazása gyógyszerkészítmények előállítására

Country Status (16)

Country Link
EP (1) EP0808166A1 (de)
JP (1) JPH11501051A (de)
CN (1) CN1177297A (de)
AR (1) AR004378A1 (de)
AU (1) AU716665B2 (de)
CA (1) CA2211161A1 (de)
CZ (1) CZ255197A3 (de)
ES (1) ES2134709B1 (de)
FR (1) FR2742052B1 (de)
HU (1) HUP9800198A2 (de)
IL (1) IL121461A0 (de)
NO (1) NO973589L (de)
PL (1) PL321779A1 (de)
TR (1) TR199700794T1 (de)
WO (1) WO1997021439A1 (de)
ZA (1) ZA9610457B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763950B1 (fr) 1997-06-02 2002-09-20 Esteve Labor Dr 2- {4- [4-(4,5-dichloro-2-methylimidazol-1-yl)butyl] -1- piperazinyl }-5-fluoropyrimidine, sa preparation et son utilisation therapeutique
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
US6046331A (en) * 1998-12-17 2000-04-04 Synaptic Pharmaceutical Corporation Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
CA2419552C (en) 2000-08-14 2010-10-12 Ortho-Mcneil Pharmaceutical, Inc. Substituted pyrazoles
DK1309592T3 (da) 2000-08-14 2006-08-21 Ortho Mcneil Pharm Inc Substituerede pyrazoler
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
MXPA03001421A (es) 2000-08-14 2004-01-26 Johnson & Johnson Pirazoles sustituidos.
CN1642973A (zh) 2000-09-06 2005-07-20 奥索-麦克尼尔药品公司 治疗变态反应的方法
US7795266B2 (en) 2003-09-25 2010-09-14 Helton David R Tetrahydroindolone derivatives for treament of neurological conditions
WO2005094827A1 (en) * 2004-03-30 2005-10-13 Kestrel Pharmaceuticals Inc. Methods for treating sexual dysfunction
PT1877390E (pt) * 2005-04-26 2010-05-31 Hypnion Inc Compostos benzisoxazole-piridina e métodos para a sua utilização
WO2006116615A1 (en) 2005-04-26 2006-11-02 Hypnion, Inc. Benzisoxazole piperazine compounds and methods of use thereof
GB2435827A (en) * 2006-03-09 2007-09-12 Del Dr Esteve S A Spain Lab Use of substituted piperazine compounds for the treatment of food related disorders
CN115304590B (zh) * 2022-09-19 2024-05-28 皮摩尔新药(辽宁)有限公司 2h-苯并三氮唑衍生物及其制备方法及含有它们的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2723091B1 (fr) * 1994-07-29 1996-11-08 Esteve Labor Dr Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles

Also Published As

Publication number Publication date
FR2742052B1 (fr) 1998-04-10
TR199700794T1 (xx) 1997-11-21
IL121461A0 (en) 1998-02-08
PL321779A1 (en) 1997-12-22
CZ255197A3 (cs) 1998-01-14
AR004378A1 (es) 1998-11-04
AU1376497A (en) 1997-07-03
CA2211161A1 (fr) 1997-06-19
ES2134709B1 (es) 2000-05-16
NO973589L (no) 1997-10-08
JPH11501051A (ja) 1999-01-26
CN1177297A (zh) 1998-03-25
WO1997021439A1 (fr) 1997-06-19
EP0808166A1 (de) 1997-11-26
AU716665B2 (en) 2000-03-02
NO973589D0 (no) 1997-08-04
MX9706133A (es) 1997-11-29
ZA9610457B (en) 1997-06-24
ES2134709A1 (es) 1999-10-01
FR2742052A1 (fr) 1997-06-13

Similar Documents

Publication Publication Date Title
HUP9800198A2 (hu) 1-{4-[4-Aril-(vagy -heteroaril)-1-piperazinil]-butil}-1H-azol-származékok alkalmazása gyógyszerkészítmények előállítására
NO307495B1 (no) Anvendelse av riluzol ved fremstilling av medikamenter for behandling av Parkinsons sykdom og Parkinsonske syndromer
PT93877A (pt) Processo para a preparacao de composicoes farmaceuticas para administracao oral de medicamentos, por exemplo antibioticos beta-lactamicos
ATE37864T1 (de) Vinylphenolderivate, ihre herstellung und verwendung.
ATE350017T1 (de) Brausetablette für die sublinguale, bukkale und gingivale verabreichung von fentanyl
DK0759757T3 (da) Orale, væskeformige alendronatformuleringer
HUP0003173A2 (hu) A GLP-1 vagy analógjainak alkalmazása szívizominfarktus kezelésére használható gyógyszerkészítmények előállítására
NL970006I2 (nl) Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.
DE59802670D1 (de) Osmotisches arzneimittelfreisetzungssystem
EP1393734A4 (de) Arzneimittel gegen darmerkrankungen
HUP9700806A2 (hu) Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására
NO982989L (no) Anvendelse av inhibitorer av den cellulµre Na+/H+-utbytteren (NHE) for fremstilling av et medikament for respiratorstimulering
TR200101163T2 (tr) Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları
KR910015300A (ko) 부스피론 : 수면 무호흡증의 치료용도
HUP0204391A2 (en) The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
HUP9901659A2 (hu) Flupirtin alkalmazása a hematopoetikus sejtrendszer károsodásával kapcsolatos megbetegedések megelőzésére és gyógyítására alkalmas gyógyszerkészítmény előállítására
HUP0401798A2 (hu) Rosuvastatin alkalmazása demencia előtti állapotokban használható gyógyszerkészítmény előállítására
DE3688787D1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
CA2436537A1 (en) Pharmaceutical compositions comprising tiotropium salts and antihistamines
JP2001316293A5 (de)
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
HUP0002905A2 (hu) 2-{4-[4-(4,5-Diklór-2-metilimidazol-1-il)butil]1-1piperazinil}-5-fluorpirimidin, előállítása és gyógyászati alkalmazása
HUP9701606A2 (hu) Szulbutiamin alkalmazása bizonyos pszichomotoros és pszichointellektuális rendellenességek kezelésére használható gyógyszerkészítmények előállítására
GLASGOW MEIE [I@ AIL